Conference paper
Glioblastoma patients treated with Nivolumab and Bevacizumab: Evidence of activated - and Nivolumab-binding T cells in tumor tissue
Department of Health Technology, Technical University of Denmark1
Experimental & Translational Immunology, Department of Health Technology, Technical University of Denmark2
T-Cells and Cancer, Experimental & Translational Immunology, Department of Health Technology, Technical University of Denmark3
Rigshospitalet4
University Hospital Herlev5
Language: | English |
---|---|
Year: | 2021 |
ISSN: | 03016323 and 03009475 |
Types: | Conference paper |
ORCIDs: | Skadborg, S. , Borch, A. and Hadrup, S. |